The national medical insurance bureau announced a number of "particularly serious" and "serious" dishonest pharmaceutical enterprises
2022-06-14
Entrusted by the national medical security administration, the medical price and bidding procurement guidance center of the national medical security administration summarized the situation of pharmaceutical enterprises rated as "particularly serious" and "serious" dishonesty in various provinces from September 19, 2021 to March 31, 2022, mainly involving the issue of giving rebates or improper benefits. Three "particularly serious" dishonest enterprises, as follows: First, Sichuan beijukang Medical Instrument Co., Ltd. According to the judgment of the people's Court of Heishui County, Mr. Liu of Sichuan beijukang medical instruments Co., Ltd. gave kickbacks or illegitimate interests to the relevant personnel of the former ABA people's Hospital, so that the class I consumables and orthopaedic consumables it operated could obtain additional trading opportunities, competitive advantages and sales volume, which was accumulated to be equivalent to more than 3.25 million yuan. The starting time of the limitation standard for dishonesty is April 30, 2021. Sichuan Provincial Pharmaceutical centralized purchasing agency assessed the enterprise as "particularly serious" dishonesty according to the provisions of the credit evaluation system for price bidding and procurement. Second, Sichuan Sifeng Pharmaceutical Co., Ltd. According to the judgment of the people's Court of Luding County, Hou of Sichuan Sifeng Pharmaceutical Co., Ltd. gave kickbacks or illegitimate interests to the relevant personnel of the former people's Hospital of Ganzi Tibetan Autonomous Prefecture, so that the piperacillin sodium for injection, Sulbactam Sodium for injection, meglumine adenosine for injection, omeprazole sodium for injection, piperacillin sodium for injection, tazobactam sodium for injection and levocarnitine for injection operated by him could obtain additional trading opportunities, competitive advantages and sales volume, The accumulated amount is equivalent to RMB 2.3 million. The starting time of the limitation standard for dishonesty is October 26, 2021. Sichuan Provincial Pharmaceutical centralized purchasing agency assessed the enterprise as "particularly serious" dishonesty according to the provisions of the credit evaluation system for price bidding and procurement. Third, Sichuan Pharmaceutical Group Shengtong Pharmaceutical Co., Ltd. According to the judgment of Xinlong County People's court, Dong, a salesman of Shengtong Pharmaceutical Co., Ltd. of Sichuan Pharmaceutical Group, gave kickbacks or illegitimate interests to the relevant personnel of the former people's Hospital of Ganzi Tibetan Autonomous Prefecture, so that the cefazolin sodium for injection, ceftizole sodium for injection and cefoxitin sodium for injection operated by him could obtain additional trading opportunities, competitive advantages and sales volume, amounting to 2.22 million yuan. The starting time of the limitation standard for dishonesty is October 26, 2021. Sichuan Provincial Pharmaceutical centralized purchasing agency assessed the enterprise as "particularly serious" dishonesty according to the provisions of the credit evaluation system for price bidding and procurement. There are three "serious" dishonest enterprises, including: Henan Xinwei Medical Instrument Co., Ltd. According to the judgment of the people's Court of Erqi District, Zhengzhou City, Ma, the medical representative of Henan Xinwei medical instruments Co., Ltd., gave kickbacks or illegitimate interests to the relevant personnel of Zhengzhou Orthopaedic Hospital, so that the as-e/s disposable anesthesia puncture bag (lumbar epidural combined bag) operated by him could obtain additional trading opportunities, competitive advantages and sales volume, which was equivalent to more than 1.09 million yuan in total. The dishonesty took effect on August 2, 2021. Henan Provincial Pharmaceutical centralized purchasing agency assessed the enterprise as "seriously" dishonest according to the provisions of the credit evaluation system for price bidding and procurement. Sichuan Pharmaceutical Group Shengtong Pharmaceutical Co., Ltd. According to the judgment of the people's Court of Luding County, Dong, a salesman of Shengtong Pharmaceutical Co., Ltd. of Sichuan Pharmaceutical Group, gave kickbacks or illegitimate interests to the relevant personnel of the former people's Hospital of Ganzi Tibetan Autonomous Prefecture, so that the cefazolin sodium for injection, ceftizole sodium for injection and cefoxitin sodium for injection operated by him could obtain additional trading opportunities, competitive advantages and sales volume, amounting to more than 660000 yuan. The time limit for breach of credit starts on October 26, 2021. Sichuan Provincial Pharmaceutical centralized purchasing agency evaluates the enterprise as "serious" breach of credit according to the provisions of the credit evaluation system for price bidding and procurement. Sichuan Zhitong Pharmaceutical Co., Ltd. According to the judgment of the people's Court of Heishui County, Mr. Liu of Sichuan Zhitong Pharmaceutical Co., Ltd. gave kickbacks or illegitimate interests to the relevant personnel of the former ABA people's Hospital, so that the Chinese herbal medicines such as Angelica sinensis and calcined mother of Pearl obtained additional trading opportunities, competitive advantages and sales volume, accumulatively equivalent to 450000 yuan. The time limit for breach of credit starts from April 30, 2021. Sichuan Provincial Pharmaceutical centralized purchasing agency evaluates the enterprise as "serious" breach of credit according to the provisions of the credit evaluation system for price bidding and procurement. According to the judgment of the people's Court of markang City, Mr. Liu of Sichuan Zhitong Pharmaceutical Co., Ltd. gave kickbacks or illegitimate interests to the relevant personnel of the former Aba Tibetan Hospital, so as to obtain additional trading opportunities, competitive advantages and sales volume for the Chinese herbal medicines such as Arnebia, antidiarrheal Muzi, etc., which were accumulated to be equivalent to more than 710000 yuan. The time limit for breach of credit starts on June 29, 2021. The Sichuan Provincial Pharmaceutical centralized purchasing agency evaluates the enterprise as "serious" breach of credit according to the provisions of the price bidding and procurement credit evaluation system. (outlook new era)
Edit：sishi Responsible editor：xingyong
Source：http://www.people.com.cn/
Special statement: if the pictures and texts reproduced or quoted on this site infringe your legitimate rights and interests, please contact this site, and this site will correct and delete them in time. For copyright issues and website cooperation, please contact through outlook new era email：lwxsd@liaowanghn.com
Recommended Reading Change it 
Home
